Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.53 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.53 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL9697312 | 0.88 | ALDH1A1 (0.69) | ALDH1A1MAPK1SLC22A2SLC22A1SLC22A3 | |
| Biphenyl SCHEMBL653702 | 0.87 | ALDH1A1 (0.82) | ALDH1A1MAPK1SLC22A2SLC22A1SLC22A3 | |
| Biphenyl SCHEMBL28890607 | 0.87 | ALDH1A1 (1.00) | ALDH1A1MAPK1SLC22A2SLC22A1SLC22A3 | |
| Biphenyl SCHEMBL4002609 | 0.87 | ALDH1A1 (1.00) | ALDH1A1MAPK1SLC22A2SLC22A1SLC22A3 | |
| Biphenyl SCHEMBL29008551 | 0.87 | ALDH1A1 (1.00) | ALDH1A1MAPK1SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL29560186 | 0.87 | ALDH1A1 (1.00) | ALDH1A1MAPK1SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL30629023 | 0.87 | ALDH1A1 (1.00) | ALDH1A1MAPK1SLC22A2SLC22A1SLC22A3 | |
| Biphenyl SCHEMBL2548048 | 0.87 | ALDH1A1 (1.00) | ALDH1A1MAPK1SLC22A2SLC22A1SLC22A3 | |
| Biphenyl SCHEMBL164 | 0.87 | ALDH1A1 (1.00) | ALDH1A1MAPK1SLC22A2SLC22A1SLC22A3 | |
| Biphenyl SCHEMBL1358618 | 0.87 | ALDH1A1 (1.00) | ALDH1A1MAPK1SLC22A2SLC22A1SLC22A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118307532-A | N2 substituted triazole-oxazoline chiral compound and preparation method and application thereof | 吉林大学 | 2024-07-09 | — | — | CN | claimed |
| CN-116425650-A | Diphenhydramine hapten and artificial antigen as well as preparation methods and applications thereof | 华南农业大学 | 2023-07-14 | — | — | CN | claimed |
| CN-114085123-A | Preparation method of diphenyl bromomethane | 浙江天酶生物工程有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-110144031-B | Method for grafting and modifying lignin by photoinduction organic catalysis | 南京工业大学 | 2020-04-21 | — | — | CN | claimed |
| CN-110283389-A | A kind of vibrating diaphragm and sounding device of sounding device | 歌尔股份有限公司 | 2019-09-27 | — | — | CN | claimed |
| EP-0334511-B1 | Oxidation process | SOLVAY INTEROX LTD (GB) | 1993-10-20 | — | — | EP | claimed |
| US-4943358-A | DIPHENYL METHANES TO BENZOQUINONES, HYDROGEN BROMIDE AND HYDROGEN PEROXIDE | INTEROX CHEMICALS LIMITED (GB) | 1990-07-24 | — | — | US | claimed |
| EP-0334511-A2 | Oxidation process | SOLVAY INTEROX LIMITED (GB) | 1989-09-27 | — | — | EP | claimed |
| JP-2173629-A | — | — | None | — | — | JP | disclosed |
| CN-122029490-A | Photosensitive resin laminate, method for forming resist pattern, and method for forming wiring board | 旭化成株式会社 | 2026-05-12 | — | — | CN | disclosed |
| CN-121949057-A | Preparation method of diphenyl bromomethane | 张涵 | 2026-05-01 | — | — | CN | disclosed |
| CN-121949057-A | Preparation method of diphenyl bromomethane | 张涵 | 2026-05-01 | — | — | CN | disclosed |
| EP-4691558-A2 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | University Court of The University of Dundee (GB) | 2026-02-11 | — | — | EP | disclosed |
| US-20250295789-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2025-09-25 | — | — | US | disclosed |
| EP-0334511-A2 | Oxidation process | SOLVAY INTEROX LIMITED (GB) | 1989-09-27 | — | — | EP | disclosed |
| US-4766109-A | HYPOTENSIVE AGENTS | SCHERING CORPORATION (US) | 1988-08-23 | — | — | US | disclosed |
| US-4447428-A | BRONCHODILATOR, ANTICOAGULANTS | GLAXO GROUP LIMITED (GB) | 1984-05-08 | — | — | US | disclosed |
| US-4409213-A | B-SIDE CHAIN ATTACHED THRU AMINO GROUP; BRONCHODILATORS, ANTICOAGUANT | GLAXO GROUP LIMITED (GB) | 1983-10-11 | — | — | US | disclosed |
| US-4265891-A | PROSTAGLANDINS, BRONCHODILATORS, PLATELET AGGREGATION INHIBITORS | GLAXO GROUP LIMITED (GB) | 1981-05-05 | — | — | US | disclosed |
| US-4028351-A | ALPHA-HALOGEN ALKYL ACETATE, N-SUBSTITUTED-4-PIPERIDONE, ACTIVATED ELEMENTAL ZINC | BUSKINE S.A. (CH) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295789-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | CYP1B1, BRCA1, UGT1A1 | ALDH1A1 32/4885MAPK1 1419/4885SLC22A2 1071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.